Household Molecular Epidemiology of Streptococcus pyogenes Carriage and Infection in The Gambia
- PMID: 40378280
- PMCID: PMC12455322
- DOI: 10.1093/infdis/jiaf252
Household Molecular Epidemiology of Streptococcus pyogenes Carriage and Infection in The Gambia
Abstract
Background: Africa experiences a high burden of Streptococcus pyogenes disease but has limited epidemiological data. We characterized emm types and emm clusters associated with carriage and disease in The Gambia, a setting with a high rheumatic heart disease burden.
Methods: A 1-year household cohort study (2021-2022) recruited 442 participants from 44 households to assess S. pyogenes carriage and noninvasive infection. Pharyngeal and skin swab samples were collected to detect carriage, and pharyngitis and pyoderma swab samples were taken to assess infection. Cultured isolates underwent emm typing and were compared with previous collection from the same region.
Results: A total of 221 cultured isolates showed 52 different emm types and 16 emm clusters. Strain diversity was high (Simpson reciprocal index, 29.3 [95% confidence interval, 24.8-36.0]), with the highest diversity seen in pyoderma and the lowest in pharyngitis. Based on available cross-opsonization data, the 30-valent M-protein vaccine candidate would cover 50.8% of the isolates, but cross-opsonization data are unknown for 38.5% of them. The emm clusters showed lower diversity and were stable over time, with 4 clusters defining 65.2% of the isolates; 68% of isolates were collected from skin sites (carriage and pyoderma), with evidence of skin-to-throat transmission in the same host.
Conclusions: This study provides a unique molecular analysis of skin and throat isolates prospectively collected from persons with carriage and noninvasive infection in Africa. Despite high strain diversity, 4 clusters included two-thirds of the isolates, representing antigen priorities for broad vaccine coverage. In this rheumatic fever-endemic setting, pyoderma and skin carriage represent an important S. pyogenes reservoir and should be included in further surveillance studies and public health interventions.
Clinical trials registration: NCT05117528.
Keywords: Streptococcus pyogenes; emm cluster; emm type; epidemiology; vaccine.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. A. Botteaux and P. R. S. are inventors on a submitted patent related to S. pyogenes vaccines. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- Craik N, Hla T, Cannon J, Moore H, Carapetis JR, Sanyahumbi A. Global disease burden of Streptococcus pyogenes. In: Ferretti JJ, Stevens DL, Fischetti VA, eds. Streptococcus pyogenes: basic biology to clinical manifestations. 2nd ed. Oklahoma City, OK: University of Oklahoma Health Sciences Center, 2022: chap 21. https://www.ncbi.nlm.nih.gov/books/NBK587099/ . - PubMed
-
- Ledford H. Why is strep A surging—and how worried are scientists? Nature 2022; 612:603. - PubMed
-
- World Health Organization . Increase in invasive group A streptococcal infections among children in Europe, including fatalities. Geneva, Switzerland: World Health Organization, 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429. Accessed 25 July 2024.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
